Invesco’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13M | Buy |
1,536,779
+641,092
| +72% | +$6.11M | ﹤0.01% | 1688 |
|
|
2025
Q4 | $10.9M | Sell |
895,687
-148,209
| -14% | -$1.8M | ﹤0.01% | 1797 |
|
|
2025
Q3 | $12.2M | Sell |
1,043,896
-494,950
| -32% | -$5.92M | ﹤0.01% | 1708 |
|
|
2025
Q2 | $14.3M | Buy |
1,538,846
+734,017
| +91% | +$5.75M | ﹤0.01% | 1583 |
|
|
2025
Q1 | $5.9M | Sell |
804,829
-85,217
| -10% | -$655K | ﹤0.01% | 2071 |
|
|
2024
Q4 | $7.6M | Buy |
890,046
+134,573
| +18% | +$1.31M | ﹤0.01% | 2020 |
|
|
2024
Q3 | $6.57M | Buy |
755,473
+709,573
| +1,546% | +$5.85M | ﹤0.01% | 2062 |
|
|
2024
Q2 | $314K | Sell |
45,900
-726,466
| -94% | -$4.48M | ﹤0.01% | 3476 |
|
|
2024
Q1 | $7.03M | Buy |
772,366
+551,339
| +249% | +$3.91M | ﹤0.01% | 2025 |
|
|
2023
Q4 | $986K | Sell |
221,027
-28,912
| -12% | -$85.5K | ﹤0.01% | 2904 |
|
|
2023
Q3 | $785K | Buy |
249,939
+71,390
| +40% | +$292K | ﹤0.01% | 2980 |
|
|
2023
Q2 | $921K | Buy |
178,549
+9,397
| +6% | +$55.9K | ﹤0.01% | 2937 |
|
|
2023
Q1 | $891K | Sell |
169,152
-96,621
| -36% | -$459K | ﹤0.01% | 2948 |
|
|
2022
Q4 | $747K | Buy |
265,773
+129,788
| +95% | +$430K | ﹤0.01% | 3077 |
|
|
2022
Q3 | $564K | Sell |
135,985
-36,958
| -21% | -$186K | ﹤0.01% | 3194 |
|
|
2022
Q2 | $695K | Buy |
172,943
+12,619
| +8% | +$47.7K | ﹤0.01% | 3168 |
|
|
2022
Q1 | $794K | Buy |
160,324
+23,225
| +17% | +$129K | ﹤0.01% | 3179 |
|
|
2021
Q4 | $955K | Buy |
137,099
+30,658
| +29% | +$238K | ﹤0.01% | 3087 |
|
|
2021
Q3 | $1.06M | Buy |
106,441
+17,923
| +20% | +$201K | ﹤0.01% | 3076 |
|
|
2021
Q2 | $1.25M | Buy |
88,518
+26,146
| +42% | +$397K | ﹤0.01% | 3039 |
|
|
2021
Q1 | $1.02M | Sell |
62,372
-938,524
| -94% | -$18.1M | ﹤0.01% | 3042 |
|
|
2020
Q4 | $20.7M | Buy |
1,000,896
+811,055
| +427% | +$12M | 0.01% | 1419 |
|
|
2020
Q3 | $1.45M | Sell |
189,841
-412,832
| -69% | -$3.43M | ﹤0.01% | 2632 |
|
|
2020
Q2 | $5.02M | Buy |
602,673
+463,694
| +334% | +$3.07M | ﹤0.01% | 1990 |
|
|
2020
Q1 | $688K | Buy |
+138,979
| New | +$686K | ﹤0.01% | 2917 |
|
|
2019
Q2 | – | Sell |
-286,118
| Closed | -$1.14M | – | 3755 |
|
|
2019
Q1 | $1.14M | Buy |
286,118
+68,470
| +31% | +$275K | ﹤0.01% | 2955 |
|
|
2018
Q4 | $866K | Buy |
217,648
+182,510
| +519% | +$1.01M | ﹤0.01% | 3058 |
|
|
2018
Q3 | $242K | Buy |
35,138
+8,955
| +34% | +$56.2K | ﹤0.01% | 3652 |
|
|
2018
Q2 | $177K | Buy |
+26,183
| New | +$180K | ﹤0.01% | 3723 |
|
|
2015
Q3 | – | Sell |
-2,767
| Closed | -$58K | – | 3931 |
|
|
2015
Q2 | $58K | Buy |
+2,767
| New | +$68.6K | ﹤0.01% | 3961 |
|
Other funds holding OCUL
DTC
ACA
SR
VA
VCM
